179 related articles for article (PubMed ID: 4118726)
1. Hypophysectomy for reactivated disseminated prostatic carcinoma.
Schoonees R; Bourke RS; Reynoso G; Murphy GP; Sćhalch DS
S Afr Med J; 1972 Sep; 46(36):1278-85. PubMed ID: 4118726
[No Abstract] [Full Text] [Related]
2. Bilateral adrenalectomy for advanced prostatic carcinoma.
Schoonees R; Schalch DS; Reynoso G; Murphy GP
J Urol; 1972 Jul; 108(1):123-5. PubMed ID: 5033992
[No Abstract] [Full Text] [Related]
3. Hypophysectomy and adrenalectomy for disseminated prostatic carcinoma.
Murphy GP; Reynoso G; Schoonees R; Gailani S; Bourke R; Kenny GM; Mirand EA; Schalch DS
J Urol; 1971 Jun; 105(6):817-25. PubMed ID: 4103890
[No Abstract] [Full Text] [Related]
4. Adrenalectomy and hypophysectomy in advanced prostatic carcinoma.
Reynoso G; Murphy GP
Cancer; 1972 Apr; 29(4):941-5. PubMed ID: 5017363
[No Abstract] [Full Text] [Related]
5. Current status of bilateral adrenalectomy or advanced prostatic carcinoma.
Bhanalaph T; Varkarakis MJ; Murphy GP
Ann Surg; 1974 Jan; 179(1):17-23. PubMed ID: 4817870
[No Abstract] [Full Text] [Related]
6. Adrenalectomy and hypophysectomy for prostatic cancer.
Brendler H
Urology; 1973 Aug; 2(2):99-102. PubMed ID: 4358703
[No Abstract] [Full Text] [Related]
7. Hypophysectomy for disseminated prostatic carcinoma.
Murphy GP; Boctor ZN; Gailani S; Belmusto L
J Surg Oncol; 1969; 1(1):81-95. PubMed ID: 4107045
[No Abstract] [Full Text] [Related]
8. [Hormonal changes in carcinoma of the prostate].
Rodrigues-Netto Júnior N; Da Silva RP; Hernández AJ
Rev Paul Med; 1979; 94(1-2):24-6. PubMed ID: 120973
[No Abstract] [Full Text] [Related]
9. Urinary pseudouridine excretion following hypophysectomy for prostatic carcinoma in man.
Schoonees R; Mittelman A; Chheda GB; Murphy GP
J Surg Oncol; 1971; 3(1):25-9. PubMed ID: 5093801
[No Abstract] [Full Text] [Related]
10. [POSSIBILITIES OF "GUIDED" ENDOCRINE-SURGICAL TREATMENT IN CANCER OF THE PROSTATE].
GIANNONI R; ZINI S; MARCELLI G
Arch Ital Urol; 1964 Apr; 36():423-40. PubMed ID: 14146744
[No Abstract] [Full Text] [Related]
11. Management of reactivated prostatic cancer.
Murphy G
Vitam Horm; 1975; 33():399-415. PubMed ID: 779252
[No Abstract] [Full Text] [Related]
12. Prostatic cancer.
Blacklock NJ
Urol Res; 1977; 5(1):1-5. PubMed ID: 324081
[No Abstract] [Full Text] [Related]
13. [Prostatic cancer: indications for hormone therapy].
Bruntsch U; Gallmeier WM
MMW Munch Med Wochenschr; 1979 Mar; 121(9):300-2. PubMed ID: 85258
[No Abstract] [Full Text] [Related]
14. Results of a Dutch Phase II trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer.
Debruyne FM; Karthaus HF; Schröder FH; de Voogt HJ; de Jong FH; Klijn JG
Prog Clin Biol Res; 1985; 185A():251-70. PubMed ID: 3929265
[No Abstract] [Full Text] [Related]
15. [Conference on the treatment of cancer of the prostate].
Richaud C
J Urol Nephrol (Paris); 1968; 74(10):769-87. PubMed ID: 4178295
[No Abstract] [Full Text] [Related]
16. The conservative treatment of prostatic carcinoma.
Klosterhalfen H
Recent Results Cancer Res; 1977; (60):78-83. PubMed ID: 405721
[No Abstract] [Full Text] [Related]
17. PROGNOSTICATION OF CARCINOMA OF THE PROSTATE METASTATIC TO THE SKELETON BY RADIOLOGICAL STUDIES.
SCHIRMER HK; RICHARDS GJ
J Urol; 1964 Dec; 92():714-20. PubMed ID: 14241206
[No Abstract] [Full Text] [Related]
18. Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate.
Huggins C; Hodges CV
CA Cancer J Clin; 1972; 22(4):232-40. PubMed ID: 4625049
[No Abstract] [Full Text] [Related]
19. [The choice of hormone treatment in breast carcinoma].
Schermuly W
Radiologe; 1966 Jan; 6(1):12-22. PubMed ID: 4165533
[No Abstract] [Full Text] [Related]
20. Pituitary ablation and disseminated prostatic carcinoma.
West CR; Murphy GP
JAMA; 1973 Jul; 225(3):253-6. PubMed ID: 4577225
[No Abstract] [Full Text] [Related]
[Next] [New Search]
